MMedication Read More New Weight Loss Drug Could Beat Ozempic’s Results—When It’s ComingJune 11, 2026 A new experimental weight loss drug from Eli Lilly could produce greater weight loss results than popular medications…
MMedication Read More FDA launches safety study for abortion pill mifepristone, source saysJune 5, 2026 The Food and Drug Administration has launched a safety study of the abortion pill mifepristone, a senior FDA…
NNutrition Read More Supplement Recalled Over ‘Fatal Physiological’ RisksJune 4, 2026 A popular dietary supplement is being pulled from the market after the U.S. Food and Drug Administration (FDA)…
NNutrition Read More 25,000 Herbal Supplement Products Recalled NationwideJune 4, 2026 In the past two months, cautions have been noted surrounding multiple herbal supplements—one report for a study that…
MMedication Read More Cingulate Receives Complete Response Letter from FDA for CTx-1301June 2, 2026 Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
MMedication Read More FDA seizes Rs 73 lakh meds for misleading claims in Maharashtra | Mumbai NewsMay 29, 2026 Mumbai: In a statewide crackdown on misleading drug advertisements and sale of misbranded medicines, the state Food and…
MMedication Read More RFK Jr.’s Push to Curb Antidepressants Has Shaken PsychiatryMay 24, 2026 Most years, when thousands of psychiatrists gather for the annual meeting of the American Psychiatric Association, they walk…
MMedication Read More Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for DaraxonrasibMay 11, 2026 Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best performing healthcare stocks so far in 2026. Revolution Medicines,…
HHealthcare Read More US FDA flags shortage of neurosurgical pads and sponges, expects disruption through 2026May 6, 2026 May 6 (Reuters) – The U.S. Food and Drug Administration on Wednesday acknowledged ongoing supply disruptions of certain…
MMedication Read More FDA Commissioner Makary defends agency’s decision on Replimune’s drugMay 5, 2026 May 5 (Reuters) – U.S. Food and Drug Administration Commissioner Dr. Marty Makary on Tuesday defended the agency’s…
MMedication Read More Xanax, One of the Most Popular Anxiety Drugs, Has Been Recalled NationwideApril 28, 2026 Prescription Medication Medicine Pill TabletsCredit: Getty NEED TO KNOW One type of the prescription anxiety medication Xanax is…
MMental health Read More Anxiety drug Xanax is under recall. Here’s what to knowApril 24, 2026 Xanax, a drug used to treat anxiety disorders, has been placed under a nationwide recall. Viatris, the maker…